Scientists are advancing research on extracellular vesicles (EVs), tiny nanoparticles naturally released by cells that carry biological information throughout the body. These microscopic “messengers” could one day deliver drugs, repair damaged tissues, regulate inflammation, and support gene therapies with greater precision than current treatments. Researchers have also identified a new manufacturing approach using nuclear magnetic resonance (NMR) technology to improve the large-scale production of EV-based therapies. Although these treatments are still in development, the findings bring regenerative medicine a step closer to creating safer, more targeted therapies for conditions such as cancer, heart disease, and immune-related disorders.
Read more at MedicalXpress